Medical System Biotechnology (300439.SZ) and Jiangxi Meikang have each obtained a medical device registration certificate.
Mekon Life Sciences (300439.SZ) announced that the company and its subsidiary Jiangxi Mekon Shengde Biotechnology Co., Ltd. (...
Medicalsystem Biotechnology (300439.SZ) announced that the company and its wholly-owned subsidiary Jiangxi Meikangshengde Biotechnology Co., Ltd. (referred to as "Jiangxi Meikang") have respectively obtained the Medical Device Registration Certificate (In Vitro Diagnostic Reagent) issued by the Zhejiang Provincial Drug Administration and the Jiangxi Provincial Drug Administration. The related products are: High-sensitivity Troponin T Test Kit (Chemiluminescent Microparticle Immunoassay) and Vascular Endothelial Growth Factor Test Kit (Chemiluminescence Immunoassay).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
